Emmanuel Moreau
French Institute of Health and Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Emmanuel Moreau.
Journal of Medicinal Chemistry | 2011
Sébastien Fortin; Lianhu Wei; Emmanuel Moreau; Jacques Lacroix; Marie-France Côté; Eric Petitclerc; Lakshmi P. Kotra; René C.-Gaudreault
Sixty-one phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates (PIB-SOs) and 13 of their tetrahydro-2-oxopyrimidin-1(2H)-yl analogues (PPB-SOs) were prepared and biologically evaluated. The antiproliferative activities of PIB-SOs on 16 cancer cell lines are in the nanomolar range and unaffected in cancer cells resistant to colchicine, paclitaxel, and vinblastine or overexpressing the P-glycoprotein. None of the PPB-SOs exhibit significant antiproliferative activity. PIB-SOs block the cell cycle progression in the G2/M phase and bind to the colchicine-binding site on β-tubulin leading to cytoskeleton disruption and cell death. Chick chorioallantoic membrane tumor assays show that compounds 36, 44, and 45 efficiently block angiogenesis and tumor growth at least at similar levels as combretastatin A-4 (CA-4) and exhibit low to very low toxicity on the chick embryos. PIB-SOs were subjected to CoMFA and CoMSIA analyses to establish quantitative structure–activity relationships.
European Journal of Medicinal Chemistry | 2010
Jean-Michel Chezal; Jan Paeshuyse; Vincent Gaumet; Damien Canitrot; Aurélie Maisonial; Claire Lartigue; Alain Gueiffier; Emmanuel Moreau; Jean-Claude Teulade; Olivier Chavignon; Johan Neyts
A series of imidazo[1,2-a]pyrrolo[2,3-c]pyridines has been prepared and evaluated for their anti-BVDV activities in MDBK cells. From the synthesized analogues bearing modifications of the substituents at positions 2, 3, 7 and 8, compounds 10a, b, 16, 24, 25 and 26 exhibited significant anti-BVDV activities.
European Journal of Medicinal Chemistry | 2008
Mounir Andaloussi; Emmanuel Moreau; Nicolas Masurier; Jacques Lacroix; René C.-Gaudreault; Jean-Michel Chezal; Anas El Laghdach; Damien Canitrot; Eric Debiton; Jean-Claude Teulade; Olivier Chavignon
Novel imidazo[1,2-a]naphthyridinic systems 6a-15a and 6b-15b were obtained from Friedländers reaction in imidazo[1,2-a]pyridine series. Most of the compounds were evaluated for their antitumor activity in the NCIs in vitro human tumor cell line screening panel. Among them, pentacyclic derivatives 13b and 14a exhibited in vitro activity comparable to anticancer agent such as amsacrine. Their mechanism of cytotoxicity action was unrelated to poisoning or inhibiting abilities against topo1. On the contrary, we highlighted a direct intercalation of the drugs into DNA by electrophoresis on agarose gel.
Journal of Organic Chemistry | 2008
Nicolas Masurier; Emmanuel Moreau; Claire Lartigue; Vincent Gaumet; Jean-Michel Chezal; Annie Heitz; Jean-Claude Teulade; Olivier Chavignon
The Duff reaction (HMTA, AcOH or TFA) was studied on substituted [6 + 5] heterocyclic compounds. This reaction provides a useful route to aldehydes for compounds bearing sensitive amide functions. It gives also access to tricyclic lactams of potential biological interest. The formation of an aminomethyl intermediate in the Duff reaction mechanism is unequivocally demonstrated.
Tetrahedron | 2003
Jean M. Chezal; Emmanuel Moreau; Olivier Chavignon; Claire Lartigue; Yves Blache; Jean C. Teulade
Abstract Novel dipyrido[1,2- a ;3′,4′- d ]imidazoles 7a – d , dipyrido[1,2- a ;4′,3′- d ]imidazoles 8a , c and pyrido[1′,2′;1,2]imidazo[4,5- d ]pyridazine derivatives 9a – d were synthesized by two pathways: thermal electrocyclic reaction of 3-alkenylimidazopyridine-2-oximes 10 and direct condensation of ethyl glycinate (or hydrazine) with 2,3-dicarbonylimidazo[1,2- a ]pyridines 11 .
European Journal of Immunology | 2005
Charalambos D. Partidos; Johan Hoebeke; Emmanuel Moreau; Olivier Chaloin; Mélanie Tunis; Guillaume Belliard; Jean-Paul Briand; Claude Desgranges; Sylviane Muller
In this study we examined the hypothesis that the binding affinity of two double‐stranded (ds) RNA motifs to HIV‐1 Tat protein might affect transactivation and the type of anti‐Tat immune responses. Using surface plasmon resonance technology we demonstrated the capacity of the poly(A):poly(U) (pA:pU) motif to bind with high affinity to a totally synthetic Tat protein and to inhibit more efficiently the Tat/transactivation response element (TAR) RNA interaction as compared to the poly(I):poly(C) (pI:pC) motif. Furthermore, the pA:pU motif was tenfold more effective in inhibiting Tat‐driven transactivation than the pI:pC motif. Following intranasal immunization of mice, both dsRNA motifs enhanced the antibody (serum and mucosal) and cellular responses to Tat. However, only the serum samples of mice immunized with Tat + pI:pC inhibited Tat‐driven transactivation. The profile of serum antibody subclasses together with the secreted cytokines by Tat‐stimulated splenocyte cultures indicated that both dsRNA motifs favored the induction of a balanced Th1 and Th2 immune response. The demonstration in this study that two dsRNA motifs had a marked effect on Tat/TAR RNA interaction and on the neutralizing capacity of anti‐Tat specific antibody responses highlights their potential for biological applications and the importance of selecting the appropriate motif as an adjuvant for vaccine design.
European Journal of Medicinal Chemistry | 2011
Sébastien Fortin; Lianhu Wei; Emmanuel Moreau; Jacques Lacroix; Marie-France Côté; Eric Petitclerc; Lakshmi P. Kotra; René C.-Gaudreault
The importance of the bridge linking the two phenyl moieties of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates (PIB-SOs) was assessed using a sulfonamide group, which is a bioisostere of sulfonate and ethenyl groups. Forty one phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamide (PIB-SA) derivatives were prepared and biologically evaluated. PIB-SAs exhibit antiproliferative activities at the nanomolar level against sixteen cancer cell lines, block the cell cycle progression in G(2)/M phase, leading to cytoskeleton disruption and anoikis. These results were subjected to CoMFA and CoMSIA analyses to establish quantitative structure-activity relationships. These results evidence that the sulfonate and sulfonamide moieties are reciprocal bioisosteres and that phenylimidazolidin-2-one could mimic the trimethoxyphenyl moiety found in the structure of numerous potent antimicrotubule agents. Finally, compounds 16 and 17 exhibited potent antitumor and antiangiogenic activities on HT-1080 fibrosarcoma cells grafted onto chick chorioallantoic membrane similar to CA-4 without significant toxicity for the chick embryos, making this class of compounds a promising class of anticancer agents.
Journal of Virology | 2004
Emmanuel Moreau; Johan Hoebeke; Daniel Zagury; Sylviane Muller; Claude Desgranges
ABSTRACT The human immunodeficiency virus Tat regulatory protein is essential for virus replication and pathogenesis. From human peripheral blood mononuclear cells of three Tat toxoid-immunized volunteers, we isolated five Tat-specific human monoclonal antibodies (HMAbs): two full-length immunoglobulin G (IgG) antibodies and three single-chain fragment-variable (scFv) antibodies. The two IgGs were mapped to distinct epitopes within the basic region of Tat, and the three scFvs were mapped to the N-terminal domain of Tat. The three scFvs were highly reactive with recombinant Tat in Western blotting or immunoprecipitation, but results were in contrast to those for the two IgGs, which are sensitive to a particular folding of the protein. In transactivation assays, scFvs were able to inhibit both active recombinant Tat and native Tat secreted by a transfected CEM cell line while IgGs neutralized only native Tat. These HMAbs were able to reduce viral p24 production in human immunodeficiency virus type 1 strain IIIB chronically infected cell lines in a dose-dependent manner.
Tetrahedron | 2002
Jean M. Chezal; Emmanuel Moreau; Olivier Chavignon; Vincent Gaumet; Jacques Métin; Yves Blache; Anna Diez; Xavier Fradera; Javier Luque; Jean C. Teulade
Abstract In order to study the regioselectivity of thermal cyclocondensation, aminoimidazo[1,2-a]pyridines (AIP) 5a–e were prepared, further converted into iminophosphoranes 7a–e , and ultimately converted regioselectively in angular annulated imidazonaphthyridines (IN) 8a , 10a , 11a , 12a or linear annulated dipyridoimidazole (DPI) 17a . From 2-substituted derivative 23 , the peri annulated product 24a was obtained. The starting amines 5a–f reacted with aldehydes to yield regioselectively IN 8a–c , 10a–c , 11a–c , 12a,b , DPI 16a–e , 17a–d and TIBO like structures (±)-13 and 24a–c , as proved by X-ray analysis. The 1,2- or 1,4-addition between amines and α,β-unsaturated aldehydes concerning the pyridine and imidazole moieties is discussed in the light of these results.
Heterocycles | 2005
Emmanuel Moreau; Jean-Claude Teulade; Nicolas Desbois; Jean-Michel Chezal; Florence Fauvelle; Jean-Claude Debouzy; Claire Lartigue; Alain Gueiffier; Yves Blache; Jean-Claude Madelmont; Olivier Chavignon
Reaction of 3-amino-2-formylimidazo[l,2-a]pyridine with various aldehydes and ketones by Friedlanders methodology afforded an entry to dipyridoimidazole, tri(tetra)azacyclopenta[b]fluorene, tri(tetra)azabenzo[b]-fluorene and triazaindeno[2,1-b]phenanthrene derivatives. Intercalation with a synthetic oligodeoxynucleotide was examined.